Roger is a Professor of Clinical Neuroscience at the University of Cambridge and a consultant Neurologist at the Addenbrooke’s Hospital. He has also been a director or lead investigator on a number of significant regenerative medicine focused initiatives such as GFORCEPD, STEMPD, the UK Regenerative Medicine Platform (UKRMP), Pluripotent Stem Cell and Engineered Cell (PSEC) Hub, the International Society for Stem Cell research (ISSCR) and is the current Lead Academic Scientist of the ARUK funded Drug Discovery Institute in Cambridge.

His research group is focused on better defining the clinical heterogeneity of two common neurodegenerative disorders of the nervous system – Parkinson’s disease (PD) and Huntington’s disease (HD). This has helped him define the best way by which to take new therapies including novel experimental therapeutics such as cell and gene therapies into the clinic.